// App-Quantinova.ai

: Cytomegalovirus (CMV) Reactivation within in the First Year after Chimeric Antigen Receptor (CAR) T Cell Therapy: Experience from the First Two Years at a Major Cancer Center

Researchers

Presenter

  • Fareed Khawaja

Principal Investigators

  • Rishab Prakash

  • Joseph Sassine

  • Guy Handley

  • Tracy VanWieren

  • Georgios Angelidakis

  • Swaminathan P. Iyer

  • Jeremy L. Ramdial

  • Sairah Ahmed

  • Yago Nieto

  • Amy Spallone

  • Ella J. Ariza-Heredia

  • Roy Chemaly

Medical Centers

  • Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX

  • The University of Texas MD Anderson Cancer Center, Houston, TX

  • MD ANDERSON CANCER CENTER, HOUSTON, TX

  • Oklahoma University College of Medicine, Oklahoma City, OK

  • Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Lymphoma/Myeloma and Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX

  • University of South Florida Morsani College of Medicine, Tampa, FL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Oncology (ONC)

Disease

  • Cytomegalovirus infection

  • Solid malignancies

Biomarkers

  • Coxsackie Virus And Adenovirus Receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved